MedTrace Logo

Effectiveness of Continuous Glucose Monitoring System Among Cardiac Surgery Patients

NCT06275971 · Status: RECRUITING · Phase: NA · Type: INTERVENTIONAL · Enrollment: 68

Last updated 2024-02-23

No results posted yet for this study

Summary

The aim of this study is to assess the level of glycemic control and the incidence of surgery-related complications in cardiac patients post-surgery when Continuous Glucose Monitoring (CGM) is utilized, as compared to traditional methods of arterial/venous blood sampling and Point-of-Care Testing (POCT) for glucose monitoring.

Conditions

Interventions

DEVICE

Dexcom G6

Glycemic control was monitored using CGM data for seven days following cardiac surgery

DEVICE

SMBG or venous/arterial blood glucose

Glycemic control was monitored using SMBG or venous/arterial blood glucose data for seven days following cardiac surgery

Sponsors & Collaborators

  • DexCom, Inc.

    collaborator INDUSTRY

  • Kangbuk Samsung Hospital

    lead OTHER

Principal Investigators

  • Sun Joon Moon, MD · Kangbuk Samsung Hospital, Sungkyunkwan University

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2022-11-24
Primary Completion
2024-06-30
Completion
2024-08-31
FDA Device
Yes

Countries

  • South Korea

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06275971 on ClinicalTrials.gov